BIOMARIN PHARMACEUTICAL INC Excess Tax Benefit from Share-based Compensation, Operating Activities
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $563.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2016-11-03
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-09-30 was $249.00K, a 219.23% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-06-30 was $215.00K.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was $99.00K, a 81.21% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-12-31 was $1.73M, a 34.29% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $2.19M, a 46.88% increase from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $1.49M, a 103.41% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $733.00K, a 54.97% increase from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $473.00K, a 13.98% increase from fiscal 2011.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|
| 2016-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $464.00K derived: sum of 2 quarters · filed 2016-11-03 | $563.00K 10-Q · filed 2016-11-03 | $2.29M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $314.00K 10-Q · filed 2016-08-08 | $2.04M derived: sum of 3 quarters · filed 2016-08-08 | $2.12M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-03-31 | $99.00K 10-Q · filed 2016-05-02 | $1.83M derived: sum of 2 quarters · filed 2016-05-02 | $1.90M derived: sum of 3 quarters · filed 2016-11-03 | $1.76M derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.80M derived: sum of 2 quarters · filed 2016-11-03 | $1.66M derived: sum of 3 quarters · filed 2016-11-03 | $2.19M 10-K · filed 2016-02-29 |
| 2015-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$64.00K derived: sum of 2 quarters · filed 2016-11-03 | $463.00K 10-Q · filed 2016-11-03 | $1.75M derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $385.00K 10-Q · filed 2016-08-08 | $1.67M derived: sum of 3 quarters · filed 2016-08-08 | $1.54M derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | $527.00K 10-Q · filed 2016-05-02 | $1.81M derived: sum of 2 quarters · filed 2016-05-02 | $1.69M derived: sum of 3 quarters · filed 2016-05-02 | $1.74M derived: sum of 4 quarters · filed 2016-05-02 |
| 2014-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.16M derived: sum of 2 quarters · filed 2016-02-29 | $1.21M derived: sum of 3 quarters · filed 2016-02-29 | $1.49M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$73.00K derived: sum of 2 quarters · filed 2015-11-02 | $205.00K 10-Q · filed 2015-11-02 | $603.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $331.00K 10-Q · filed 2015-08-05 | $729.00K derived: sum of 3 quarters · filed 2016-02-29 | $611.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $278.00K 10-Q · filed 2015-05-05 | $676.00K derived: sum of 2 quarters · filed 2016-02-29 | $558.00K derived: sum of 3 quarters · filed 2016-02-29 | $883.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $398.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $280.00K derived: sum of 2 quarters · filed 2016-02-29 | $605.00K derived: sum of 3 quarters · filed 2016-02-29 | $733.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $207.00K derived: sum of 2 quarters · filed 2014-10-28 | $335.00K 10-Q · filed 2014-10-28 | $712.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $453.00K 10-Q · filed 2014-07-31 | $830.00K derived: sum of 3 quarters · filed 2015-03-02 | $842.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $128.00K 10-Q · filed 2014-05-02 | $505.00K derived: sum of 2 quarters · filed 2015-03-02 | $517.00K derived: sum of 3 quarters · filed 2015-03-02 | $583.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $389.00K derived: sum of 2 quarters · filed 2015-03-02 | $455.00K derived: sum of 3 quarters · filed 2015-03-02 | $473.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $78.00K derived: sum of 2 quarters · filed 2013-10-28 | $96.00K 10-Q · filed 2013-10-28 | $402.00K derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $84.00K 10-Q · filed 2013-07-29 | $390.00K derived: sum of 3 quarters · filed 2014-02-26 | $471.00K derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $18.00K 10-Q · filed 2013-04-29 | $324.00K derived: sum of 2 quarters · filed 2014-02-26 | $405.00K derived: sum of 3 quarters · filed 2014-02-26 | $18.00K derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $387.00K derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $415.00K 10-K · filed 2014-02-26 |
| 2011-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | -$306.00K derived: sum of 2 quarters · filed 2012-10-29 | $109.00K 10-Q · filed 2012-10-29 | $618.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $28.00K 10-Q · filed 2012-08-02 | $537.00K derived: sum of 3 quarters · filed 2013-02-26 | $556.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $415.00K 10-Q · filed 2012-04-30 | $924.00K derived: sum of 2 quarters · filed 2013-02-26 | $943.00K derived: sum of 3 quarters · filed 2013-02-26 | $956.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $528.00K derived: sum of 2 quarters · filed 2013-02-26 | $541.00K derived: sum of 3 quarters · filed 2013-02-26 | $541.00K 10-K · filed 2013-02-26 |
| 2010-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $32.00K derived: sum of 2 quarters · filed 2011-10-31 | $32.00K 10-Q · filed 2011-10-31 | $14.00K derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $13.00K 10-Q · filed 2011-08-01 | -$5.00K derived: sum of 3 quarters · filed 2012-02-22 | -$5.00K derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $0.00 10-Q · filed 2011-04-29 | -$18.00K derived: sum of 2 quarters · filed 2012-02-22 | -$18.00K derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$18.00K derived: sum of 2 quarters · filed 2012-02-22 | $113.00K 10-K · filed 2012-02-22 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $131.00K 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $131.00K 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $960.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |